Entrada Therapeutics Inc [TRDA] Director makes an insider sale of 27,000 shares worth $0.2 million.

Entrada Therapeutics Inc’s recently made public that its Director PARMAR KUSH unloaded Company’s shares for reported $0.2 million on Jul 09 ’25. In the deal valued at $7.50 per share,27,000 shares were sold. As a result of this transaction, PARMAR KUSH now holds 1,093,313 shares worth roughly $5.64 million.

Then, 5AM Ventures V, L.P. sold 20,065 shares, generating $150,528 in total proceeds. Upon selling the shares at $7.50, the 10% Owner now owns 3,163,066 shares.

Before that, 5AM Ventures V, L.P. sold 6,935 shares. Entrada Therapeutics Inc shares valued at $52,026 were divested by the 10% Owner at a price of $7.50 per share. As a result of the transaction, 5AM Ventures V, L.P. now holds 1,093,313 shares, worth roughly $5.64 million.

ROTH MKM initiated its Entrada Therapeutics Inc [TRDA] rating to a Buy in a research note published on December 06, 2024; the price target was $29. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in early January with a ‘”an Outperform”‘ rating. H.C. Wainwright began covering TRDA with “Buy” recommendation on April 03, 2023.

Price Performance Review of TRDA

On Tuesday, Entrada Therapeutics Inc [NASDAQ:TRDA] saw its stock jump 2.79% to $5.16. Over the last five days, the stock has lost -11.49%. Entrada Therapeutics Inc shares have fallen nearly -64.29% since the year began. Nevertheless, the stocks have fallen -70.16% over the past one year. While a 52-week high of $21.79 was reached on 01/03/25, a 52-week low of $4.93 was recorded on 08/11/25.

Levels Of Support And Resistance For TRDA Stock

The 24-hour chart illustrates a support level at 5.06, which if violated will result in even more drops to 4.97. On the upside, there is a resistance level at 5.22. A further resistance level may holdings at 5.29.

How much short interest is there in Entrada Therapeutics Inc?

A steep rise in short interest was recorded in Entrada Therapeutics Inc stocks on 2025-07-31, dropping by -0.11 million shares to a total of 1.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 1.25 million shares. There was a decline of -9.25%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.